Revenue and Financial Performance - For the three months ended March 31, 2024, the company generated 49,790inrevenue,asignificantincreasecomparedtonorevenueinthesameperiodof2023[131].−ThenetlossforthethreemonthsendedMarch31,2024was6.9 million, compared to a net loss of 2.6millioninthesameperiodof2023,reflectinganincreaseof4.2 million[130]. - The company incurred a net loss of approximately 6.9millionduringthethreemonthsendedMarch31,2024,withcashusedinoperatingactivitiesofapproximately4.5 million[145]. - Cash provided by financing activities during the three months ended March 31, 2024 was approximately 6.3million,primarilyfromthesaleofCommonStock[148].−Thecompanyexpectstocontinueincurringlossesandnegativecashflowsduetoincreasedexpensesrelatedtoproductresearchanddevelopment[137].Expenses−GeneralandadministrativeexpensesforthethreemonthsendedMarch31,2024wereapproximately6.5 million, an increase of approximately 3.9millionfrom2.6 million in the same period of 2023[132]. - Research and development expenses for the three months ended March 31, 2024 were approximately 0.3million,anincreaseofapproximately0.2 million compared to 2,000inthesameperiodof2023[134].−TotaloperatingexpensesforthethreemonthsendedMarch31,2024were6.8 million, an increase of 4.2millionfrom2.6 million in the same period of 2023[128]. - The company expects to incur significant operating costs related to research and development, capital expenditures, and general administrative expenses as it scales operations[119]. - The company anticipates an increase in professional fees and other public company costs following the completion of the merger[121]. Capital and Financing - As of March 31, 2024, the company had cash of approximately 3.3millionandanaccumulateddeficitofapproximately20.2 million[137]. - The company had four outstanding bank loans totaling approximately 0.9million,withinterestratesrangingfrom4.6670.6 million with a related party, maturing on June 25, 2025[140]. - The company received 5.5millionfromAFGinMarch2024,concurrentwiththeMerger,butdidnotreceivenetcashduetotransactionexpenses[138].ResearchandDevelopment−ThecompanyhasongoingresearchanddevelopmentsponsorshipagreementswithKoreaUniversity,withtotalpaymentsexpectedtoreachapproximately0.4 million in 2024[142]. - The company has a patent portfolio that is expected to be a cornerstone of its artificial intelligence solutions targeting industries such as automotive, healthcare, and financial services[112]. Business Combination - The company entered into a business combination with DHC on March 14, 2024, issuing 25,641,321 shares of common stock to Prior BEN stockholders[113]. Internal Controls - Management has identified a material weakness in internal controls over financial reporting, which has not yet been remediated[159].